1. |
Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th edition. Lyon: IARC Press. 2010.
|
2. |
李增山, 李青. 2010年版消化系统肿瘤WHO分类解读. 中华病理学杂志, 2011, 40(5): 351-354.
|
3. |
Estrozi B, Bacchi CE. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo), 2011, 66(10): 1671-1675.
|
4. |
Kuo CH, Hsieh CC, Chan ML, et al. Small cell carcinoma of the esophagus: a report of 16 cases from a single institution and literature review. Ann Thorac Surg, 2011, 91(2): 373-378.
|
5. |
Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol, 2008, 32(9): 1404-1411.
|
6. |
Frazier SR, Kaplan PA, Loy TS. The pathology of extrapulmonary small cell carcinoma. Semin Oncol, 2007, 34(1): 30-38.
|
7. |
Nekulova M, Holcakova J, Coates P, et al. The role of p63 in cancer, stem cells and cancer stem cells. Cell Mol Biol Lett, 2011, 16(2): 296-327.
|
8. |
Huang Q, Wu H, Nie L, et al. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol, 2013, 37(4): 467-483.
|
9. |
Li AF, Li Ac, Hsu CY, et al. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features. J Clin Patllol, 2010, 63(7): 620-625.
|
10. |
Lu J, Xue LY, Lu N, et al. Superficial primary small cell carcinoma of the esophagus: clinic pathological and immunohistochemical analysis of 15 cases. Dis esophagus, 2010, 23(2): 153-159.
|
11. |
周海榆, 陈刚, 林华欢, 等.原发性食管神经内分泌癌影像学及病理特征. 广州医学院学报, 2011, 39(1): 24-28.
|
12. |
Lu XJ, Luo JD, Ling Y, et al. Management of small cell carcinoma of esophagus in china. J Gastrointest Surg, 2013, 17(7): 1181-1187.
|
13. |
邵明雯, 孙婧, 马兰, 等. 具有神经内分泌性质食管癌的临床病理特点及生存分析. 中华肿瘤防治杂志, 2014, 21(24): 1980-1985.
|
14. |
邵令方, 王其彰, 主编. 新编食管外科学. 石家庄: 河北科学技术出版社, 2006. 568-569.
|
15. |
隋燕霞, 张勇, 党诚学, 等. 食管原发性神经内分泌癌33例临床病理分析. 胃肠病学, 2014, 19(3): 139-142.
|
16. |
袁柏思, 金鑫鑫, 刘炯, 等. 食管神经内分泌癌: 临床病例回顾性分析. 诊断病理学杂志, 2015, 22(12): 740-743.
|
17. |
高静, 徐鲁白, 王继生, 等. 食管神经内分泌癌七例并文献复习. 肿瘤研究与临床, 2015, 27(8): 561-564.
|
18. |
Ding J, Ji J, Zhu W, et al. A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis. Dis Esophagus, 2013, 26 (7): 696-702.
|
19. |
Chen SB, Yang JS, Yang WP, et al. Treatmentand prognosis of limited disease primary small cell carcinoma of esophagus. Dis Esophagus, 2011, 24(2): 114-119.
|
20. |
焦文鹏, 曹峰, 王军. 食管小细胞癌研究现状. 中华肿瘤防治杂志, 2015, 22(4): 315-319.
|
21. |
Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas, 2010, 39(6): 799-800.
|
22. |
Eriksson B, Annibale B, Bajetta E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors. Neuroendocrinology, 2009, 90(2): 214-219.
|
23. |
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Vol 10. Fort Washington: National Comprehensive Cancer Network. 2010.
|
24. |
Lu ZH, Li J, Lu M, et al. Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas. Med Oncol, 2013, 30(3): 664.
|
25. |
梁后杰, 杨晨. 胃肠胰腺神经内分泌肿瘤治疗共识(NCCN、ENETs、NANETs)解读. 临床肿瘤学杂志, 2011, 16(11): 1039-1043.
|